Correction: Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
暂无分享,去创建一个
P. Nelson | K. Schughart | C. Basler | M. Bahgat | Bastian Hatesuer | Nora Mehnert | Stephanie Bertram | Stefan Pö Hlman
[1] K. Shirato,et al. Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2 , 2013, Journal of Virology.
[2] G. Whittaker,et al. Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12* , 2013, The Journal of Biological Chemistry.
[3] Christian Drosten,et al. The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies , 2013, Journal of Virology.
[4] D. Steinhauer,et al. Influenza HA Subtypes Demonstrate Divergent Phenotypes for Cleavage Activation and pH of Fusion: Implications for Host Range and Adaptation , 2013, PLoS pathogens.
[5] H. Klenk,et al. Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. , 2012, Vaccine.
[6] K. Schughart,et al. The Mouse as Model System to Study Host‐Pathogen Interactions in Influenza A Infections , 2012, Current protocols in mouse biology.
[7] P. Nelson,et al. Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts , 2012, PloS one.
[8] Maria Zambon,et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. , 2012, The Lancet. Infectious diseases.
[9] H. Klenk,et al. Aprotinin and similar protease inhibitors as drugs against influenza. , 2011, Antiviral research.
[10] K. Schughart,et al. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. , 2011, Virology.
[11] Christian Drosten,et al. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response , 2011, Journal of Virology.
[12] K. Schughart,et al. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection , 2011, Virology Journal.
[13] D. A. Stein,et al. Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2 , 2010, Journal of Virology.
[14] Jincun Zhao,et al. A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.
[15] Makoto Takeda,et al. Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 , 2010, Journal of Virology.
[16] K. Schughart,et al. TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells , 2010, Journal of Virology.
[17] S. Pöhlmann,et al. Novel insights into proteolytic cleavage of influenza virus hemagglutinin , 2010, Reviews in medical virology.
[18] Hang Xie,et al. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. , 2010, Journal of virological methods.
[19] Semi Kim,et al. Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin , 2009, Journal of Virology.
[20] M. Takeda,et al. Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2 , 2008, Journal of Virology.
[21] G. Kochs,et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene , 2007, Proceedings of the National Academy of Sciences.
[22] H. Yamada,et al. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. , 2007, Current pharmaceutical design.
[23] H. Klenk,et al. Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium , 2006, Journal of Virology.
[24] P. Nelson,et al. Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease , 2006, Molecular and Cellular Biology.
[25] H. Klenk,et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Wright,et al. Cleavage of Influenza A Virus Hemagglutinin in Human Respiratory Epithelium Is Cell Associated and Sensitive to Exogenous Antiproteases , 2002, Journal of Virology.
[27] R. Webster,et al. Characterization of the Influenza A Virus Gene Pool in Avian Species in Southern China: Was H6N1 a Derivative or a Precursor of H5N1? , 2000, Journal of Virology.
[28] O. Zhirnov,et al. Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. , 1994, Antiviral research.
[29] N. Katunuma,et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. , 1992, The Journal of biological chemistry.
[30] M. Vey,et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin‐like endoprotease. , 1992, The EMBO journal.
[31] B. Gotoh,et al. Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation , 1992, FEBS letters.
[32] M. Hamaguchi,et al. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. , 1990, The EMBO journal.
[33] O. Zhirnov,et al. High protection of animals lethally infected with influenza virus by aprotinin‐rimantadine combination , 1987, Journal of medical virology.
[34] O. Haller,et al. Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes , 1979, The Journal of experimental medicine.
[35] H. Klenk,et al. Activation of influenza A viruses by trypsin treatment. , 1975, Virology.
[36] P. Choppin,et al. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.
[37] 村上 明子. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus , 2003 .
[38] O. Zhirnov,et al. Suppression of influenza virus replication in infected mice by protease inhibitors. , 1984, The Journal of general virology.